Investors | Odigent

Investor Information

At Odigent, we are advancing the future of early disease detection and precision diagnostics through AI-driven software and FDA-aligned medical technology. We invite mission-aligned partners to join us in building the next generation of healthcare innovation.

Share Price: $1.50

Shares Offered: 1,000,000

Share Class: Common

Download Private Placement Memorandum for more information on Offering.

Our Mission

To empower clinicians with intelligent diagnostic tools that detect disease earlier, improve outcomes, and save lives.

Access Investor Materials

Qualified investors may request access to our offering materials, including our Private Placement Memorandum (PPM) and executive briefing documents.

Download Private Placement Memorandum

For secure access to additional investor information, please contact:
📧 info@odigent.com

Why Invest in Odigent

AI-powered diagnostic platform (Radilect AI)
Next-generation medical devices for early cancer detection
Strong regulatory foundation (FDA 510(k), ISO 13485)
Mission-driven leadership team
Scalable commercial roadmap across clinical and research markets

Innovation & Focus Areas

AI diagnostic workflows and radiology automation
Medical device development for cancer screening & cell sampling
Data-driven clinical insights
Precision medicine research and early-stage detection technologies

Legal and Compliance Notice

This page is for informational purposes only and does not constitute an offer to sell or a solicitation to purchase securities. Any securities offering is made only through official offering documents to qualified investors, in accordance with applicable securities laws and regulations.

Past performance is not indicative of future results. Investing in early-stage ventures involves substantial risk, including the potential loss of investment.

✅ Investor FAQ

What is Odigent?

Odigent is a medical technology company focused on AI-powered diagnostics and precision medical devices for early cancer detection.

Who can invest?

Accredited investors and qualified institutions under Regulation D.

How do I access the PPM and offering documents?

Request secure access via the form below or contact info@odigent.com.

What stage is Odigent in?

Pre-commercial growth, with R&D, regulatory preparation, and technology development underway.

Is this a solicitation or guarantee?

No. This is informational only. Full details are provided in the official offering documents to qualified investors.

Investor Verification & Confidentiality

To proceed, you acknowledge that:

You are an accredited investor or operating on behalf of a qualified entity
You will not redistribute or share offering documents without written authorization
You understand this does not constitute an offer to sell securities

Click to continue and view confidential investor materials.

Download Investor Overview

Legal Disclaimer

This webpage and any linked materials are for informational purposes only and do not constitute an offer to sell or a solicitation to buy securities. Any securities offering will be made only to qualified investors through official offering documents and in compliance with applicable securities laws. Past results do not guarantee future performance. Investing in early-stage companies involves significant risk, including the possible loss of capital.